CN105362875A - Medicine for treating cystoparalysis - Google Patents

Medicine for treating cystoparalysis Download PDF

Info

Publication number
CN105362875A
CN105362875A CN201410426805.2A CN201410426805A CN105362875A CN 105362875 A CN105362875 A CN 105362875A CN 201410426805 A CN201410426805 A CN 201410426805A CN 105362875 A CN105362875 A CN 105362875A
Authority
CN
China
Prior art keywords
parts
medicine
cystoparalysis
treating
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410426805.2A
Other languages
Chinese (zh)
Inventor
李东海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410426805.2A priority Critical patent/CN105362875A/en
Publication of CN105362875A publication Critical patent/CN105362875A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating cystoparalysis. The medicine is prepared from, by weight, 8-12 parts of mantis egg-case, 8-12 parts of sharpleaf galangal fruits, 8-12 parts of Chinese yam, 8-12 parts of schisandra chinensis, 8-12 parts of lindera aggregate, 8-12 parts of rehmannia glutinosa, 4-8 parts of radix aconiti lateralis preparata, 4-8 parts of cinnamon, 8-12 parts of raspberries, 8-12 parts of true bone ceramic and 8-12 parts of herba epimedii. According to the medicine for treating cystoparalysis, eleven natural traditional Chinese medicines are selected for compatibility, the raw materials act cooperatively to achieve the functions of dispelling wind and eliminating dampness, reinforcing the kidney to strengthen yang, warming the spleen and stimulating the appetite, tonifying blood and nourishing yin, replenishing essence and benefiting marrow, soothing the liver and regulating the circulation of qi, suppressing liver yang and soothing the nerves, securing essence and reducing urination and the like, both causes and symptoms are treated, and the medicine is good in cystoparalysis treatment effect and free of toxic and side effects. Besides, a preparation method of the medicine is simple, the treatment course is short, the medicine is convenient to take and low in cost, and the effective rate is 90% or above.

Description

A kind of medicine for the treatment of cystoparalysis
Technical field
The present invention relates to Chinese medicine, specifically a kind of medicine for the treatment of cystoparalysis.
Background technology
Cystoparalysis is exactly the urinary incontinence usually said, is to lose due to sphincter vesicae damage or delayed ischemic neurological deficits self-control of urinating, and urine is not independently flowed out.
According to clinical symptoms, stress incontinence can be divided into three degree:
Slight: general activity and night without urinary incontinence, abdominal pressure increase time accidental urinary incontinence;
Moderate: abdominal pressure increase and stand up activity time, have urinary incontinence frequently, need to wear diaper life;
Severe: stand up activity or clinostatism position chanP time have urinary incontinence, seriously affect life and the doings of patient.
Remedy measures mainly operative treatment conventional at present.
Summary of the invention
The medicine of the treatment cystoparalysis the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, having no side effect.
The technical scheme realizing the object of the invention is:
Treating a medicine for cystoparalysis, is be made up of the raw material of following weight proportioning:
Ootheca Mantidis 8-12 part, Fructus Alpiniae Oxyphyllae 8-12 part, Rhizoma Dioscoreae 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Radix Linderae 8-12 part, Radix Rehmanniae Preparata 8-12 part, Radix Aconiti Lateralis Preparata 4-8 part, Cortex Cinnamomi 4-8 part, Fructus Rubi 8-12 part, Os Draconis (calcined) 8-12, Herba Epimedii 18-12 part.
Preferably, the optimum weight proportioning of each raw material is:
Ootheca Mantidis 10 parts, Fructus Alpiniae Oxyphyllae 10 parts, Rhizoma Dioscoreae 10 parts, Fructus Schisandrae Chinensis 10 parts, the Radix Linderae 10 parts, 10 parts, Radix Rehmanniae Preparata, Radix Aconiti Lateralis Preparata 6 parts, Cortex Cinnamomi 6 parts, Fructus Rubi 10 parts, Os Draconis (calcined) 10, Herba Epimedii 10 parts.
Described crude drug is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take each crude drug by weight ratio, adds the water of 5-10 times of crude drug total amount, boils rear slow fire and boils 10-20 minute, filter and remove residue, to obtain final product with big fire.
Instructions of taking: every day three times, each 30 milliliters, general 5-7 day and effective.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, effect of each crude drug is as follows:
Ootheca Mantidis: salty sweet, flat, enter liver, kidney channel, urinary bladder channel.Controlling nocturnal emission with astringent drugs reducing urination, effect of reinforcing the kidney and supporting YANG.
Fructus Alpiniae Oxyphyllae: acrid in the mouth, warm in nature, returns spleen, kidney channel.There is the kidney warming controlling nocturnal emission with astringent drugs, warming the spleen appetizing, take the photograph effect of expectorant reducing urination.
Rhizoma Dioscoreae: sweet in the mouth, property are flat.Be included into lung, spleen, kidney channel.There is strengthening the spleen and stomach, lung benefiting kidney, tonify deficiency are won, strong skin care, tonify deficiency are anti-ageing, the effect such as benefiting qi and nourishing blood, nourishing YIN and invigorating YANG, strengthening vital QI to eliminate pathogenic factors.
Fructus Schisandrae Chinensis: sour in the mouth, warm in nature, nontoxic, returns, lung meridian, kidney channel.Have and astringe the lung, nourishing kidney, promote the production of body fluid, receive the effect such as antiperspirant, arresting seminal emission.
The Radix Linderae: bitter in the mouth, sweet, puckery, slightly warm in nature, returns liver, kidney channel.There is nourishing the blood and yin, loosening bowel to relieve constipation, preventing the attack (or recurrence) of malaria, the effect of dispeling the wind, detoxifying.
Radix Rehmanniae Preparata: sweet in the mouth, slightly warm in nature.Return liver, kidney channel.There is YIN nourishing of enriching blood, life essence-filling, marrow-benefitting effect.
Radix Aconiti Lateralis Preparata: acrid in the mouth, micro-hardship, sweet, property are put down, Gui Jing: enter spleen, stomach, lung meridian.There is the effect such as depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving.
Cortex Cinnamomi: bitter in the mouth, cold in nature, nontoxic, GUIXIN warp, Liver Channel, lung meridian, stomach are through, tri-jiao channel.There is the effects such as pathogenic fire purging relieving restlessness, heat clearing away profit, removing pathogenic heat from blood and toxic substance from the body.
Fructus Rubi: sweet, micro-acid, tepor, enter liver, kidney channel.There is effect of the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination.Main impotence and premature ejaculation, emission and spermatorrhea, leukorrhagia is rare clearly, frequent micturition incontinence of urine, and blurred vision is dark, early whitening of beard and hair.
Os Draconis (calcined): sweet in the mouth, puckery, property are put down, and enter the heart, liver, kidney channel.There is effect of subduing hyperactive YANG to ease mental disorders.Forging rear merit restrains astringent or styptic treatment for spontaneous sweating partially, is used for premature ejaculation of passing out semen.
Herba Epimedii: acrid in the mouth, sweet, warm in nature, returns liver, kidney channel.There is effect of kidney invigorating and YANG supporting, expelling wind and removing dampness.
11 kinds of natural Chinese medicine compatibilities chosen by the medicine that the present invention treats cystoparalysis, each crude drug synergism plays the effect such as expelling wind and removing dampness, reinforcing the kidney and supporting YANG, warming the spleen appetizing, YIN nourishing of enriching blood, life essence-filling, marrow-benefitting, depressed liver-energy dispersing and QI regulating, subduing hyperactive YANG to ease mental disorders, controlling nocturnal emission with astringent drugs reducing urination, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment cystoparalysis, have no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, cost is low, and effective percentage reaches more than 90%.
Detailed description of the invention
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
Treat a medicine for cystoparalysis, the weight proportion of each raw material is:
Ootheca Mantidis 8 parts, Fructus Alpiniae Oxyphyllae 8 parts, Rhizoma Dioscoreae 8 parts, Fructus Schisandrae Chinensis 8 parts, the Radix Linderae 8 parts, 8 parts, Radix Rehmanniae Preparata, Radix Aconiti Lateralis Preparata 4 parts, Cortex Cinnamomi 4 parts, Fructus Rubi 8 parts, Os Draconis (calcined) 8, Herba Epimedii 8 parts.Decoct into decoction oral according to a conventional method.
Embodiment 2:
Treat a medicine for cystoparalysis, the weight proportion of each raw material is:
Ootheca Mantidis 10 parts, Fructus Alpiniae Oxyphyllae 10 parts, Rhizoma Dioscoreae 10 parts, Fructus Schisandrae Chinensis 10 parts, the Radix Linderae 10 parts, 10 parts, Radix Rehmanniae Preparata, Radix Aconiti Lateralis Preparata 6 parts, Cortex Cinnamomi 6 parts, Fructus Rubi 10 parts, Os Draconis (calcined) 10, Herba Epimedii 10 parts.Decoct into decoction oral according to a conventional method.
Embodiment 3:
Treat a medicine for cystoparalysis, the weight proportion of each raw material is:
Ootheca Mantidis 12 parts, Fructus Alpiniae Oxyphyllae 12 parts, Rhizoma Dioscoreae 12 parts, Fructus Schisandrae Chinensis 12 parts, the Radix Linderae 12 parts, 12 parts, Radix Rehmanniae Preparata, Radix Aconiti Lateralis Preparata 8 parts, Cortex Cinnamomi 8 parts, Fructus Rubi 12 parts, Os Draconis (calcined) 12, Herba Epimedii 12 parts.Decoct into decoction oral according to a conventional method.
Experimental example:
In order to prove the clinical efficacy of medicine of the present invention further, selecting 30 routine patients, clinical observation is carried out to the curative effect of medicine of the present invention.
Efficacy determination based on transference cure, and changes situation with reference to effect etc., is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improvement or DeGrain.
Apply in Drug therapy cystoparalysis 30 example of the present invention, man 20 example, female 10 example.Fundamental symptoms is: abdominal pressure increase and stand up activity time, have urinary incontinence, weak, the soreness of waist etc. frequently.After oral Drug therapy of the present invention, symptom all has certain improvement, and wherein effective 27 examples, have 29 examples, invalid 1 example, effective percentage 97%.

Claims (2)

1. treat a medicine for cystoparalysis, it is characterized in that being made up of the raw material of following weight proportioning:
Ootheca Mantidis 8-12 part, Fructus Alpiniae Oxyphyllae 8-12 part, Rhizoma Dioscoreae 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Radix Linderae 8-12 part, Radix Rehmanniae Preparata 8-12 part, Radix Aconiti Lateralis Preparata 4-8 part, Cortex Cinnamomi 4-8 part, Fructus Rubi 8-12 part, Os Draconis (calcined) 8-12, Herba Epimedii 8-12 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is:
Ootheca Mantidis 10 parts, Fructus Alpiniae Oxyphyllae 10 parts, Rhizoma Dioscoreae 10 parts, Fructus Schisandrae Chinensis 10 parts, the Radix Linderae 10 parts, 10 parts, Radix Rehmanniae Preparata, Radix Aconiti Lateralis Preparata 6 parts, Cortex Cinnamomi 6 parts, Fructus Rubi 10 parts, Os Draconis (calcined) 10, Herba Epimedii 10 parts.
CN201410426805.2A 2014-08-27 2014-08-27 Medicine for treating cystoparalysis Pending CN105362875A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410426805.2A CN105362875A (en) 2014-08-27 2014-08-27 Medicine for treating cystoparalysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410426805.2A CN105362875A (en) 2014-08-27 2014-08-27 Medicine for treating cystoparalysis

Publications (1)

Publication Number Publication Date
CN105362875A true CN105362875A (en) 2016-03-02

Family

ID=55365827

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410426805.2A Pending CN105362875A (en) 2014-08-27 2014-08-27 Medicine for treating cystoparalysis

Country Status (1)

Country Link
CN (1) CN105362875A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115671226A (en) * 2022-11-15 2023-02-03 上海市第七人民医院(上海中医药大学附属第七人民医院) Traditional Chinese medicine composition for treating stress urinary incontinence and preparation method of ointment of traditional Chinese medicine composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101204553A (en) * 2007-11-29 2008-06-25 北京中科雍和医药技术有限公司 Chinese traditional medicine for uroclepsia, impotence and prospermia and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101204553A (en) * 2007-11-29 2008-06-25 北京中科雍和医药技术有限公司 Chinese traditional medicine for uroclepsia, impotence and prospermia and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
实用临证中药手册: "《实用临证中药手册》", 30 April 1996, 人民军医出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115671226A (en) * 2022-11-15 2023-02-03 上海市第七人民医院(上海中医药大学附属第七人民医院) Traditional Chinese medicine composition for treating stress urinary incontinence and preparation method of ointment of traditional Chinese medicine composition

Similar Documents

Publication Publication Date Title
CN101564521B (en) External plaster for treating hyperplasia of mammary glands
CN103520654B (en) A kind of Chinese medicine composition being used for the treatment of knee osteoarthritis and preparation method thereof
CN100551422C (en) A kind of endo-medicine for the treatment of intervertebral disk hernia
CN103877247B (en) Medicine being used for the treatment of decubital ulcer and preparation method thereof
CN103432559B (en) Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof
CN105664099A (en) Traditional Chinese medicine composition for warming and invigorating kidney yang and preparation method thereof
CN103933497A (en) Chinese medicinal composition for treating constipation
CN102552608B (en) Medicine composition used for treating fracture and bone injury, preparation method thereof, and purpose thereof
CN106390077A (en) Pharmaceutical composition for treating stomachache and diarrhea and preparation method and application thereof
CN103006980B (en) Chinese medicinal composition for treating distention and fullness
CN105232987A (en) Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation
CN103083604A (en) Essence boosting and kidney tonifying soup
CN105362875A (en) Medicine for treating cystoparalysis
CN102836276B (en) Bone spur softening pill for treating osteoarthritis
CN103202985A (en) Traditional Chinese medicine used for treating lumbar spondylosis, cervical spondylosis, sciatica and rheumatism and preparation method thereof
CN102846741B (en) Navel-applied plaster for treating sequelae of hemiplegia and preparation method thereof
CN106361918A (en) Traditional Chinese medicine patch for treating deficiency of kidney-yang
CN104689240A (en) Medicine for treating Qi-stagnation and blood stasis type chloasma and preparation method thereof
CN104815101A (en) Externally used medicine for treating climacteric syndrome and preparation method thereof
CN105031505A (en) Medicine for treating benign prostatic hyperplasia hypertrophy and preparation method thereof
CN102772620B (en) Medicine for inhibiting recurrence of cancer after surgery
CN104258058A (en) Traditional Chinese medicine for treating juvenile canities
CN105412322A (en) Traditional Chinese medicine preparation for treating diabetic peripheral neuropathic pain and preparation method thereof
CN104107304A (en) Traditional Chinese medicinal composition for treating poliosis
CN105079522A (en) Medicine for treating chronic prostatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160302

WD01 Invention patent application deemed withdrawn after publication